2-BBB Medicines

2-BBB Medicines is a private, clinical-stage biotech leveraging its proprietary G-Technology® liposomal platform to enhance drug delivery to the central nervous system and eyes. Originating from Leiden University, the company partners with pharma and biotech firms to develop improved therapies for oncology, neurology, and retinal diseases. Its strategy centers on de-risking development by applying its delivery technology to known compounds, with several partnered programs already in the clinic.

G-Technology®, a proprietary CNS-targeted liposome formulation designed to safely enhance drug delivery across the blood-brain barrier and blood-retina barrier.

2-BBB competes in the dynamic field of blood-brain barrier drug delivery, which includes approaches like focused ultrasound with microbubbles, nanoparticle systems, prodrug strategies, and receptor-mediated transport. Its differentiation lies in a liposome-based platform with specific targeting ligands and a partnering-focused business model for known compounds.